Epidemiologic features of Kawasaki disease in Taiwan, 1996-2002

Pediatrics

Volumn 114, Issue 6, 2004, Pages

  Chang, Luan Yin ^a   Chang, I Shou ^b   Lu, Chun Yi ^a   Chiang, Bor Luen ^a   Lee, Chin Yun ^a   Chen, Pei Jer ^a   Wang, Jin Town ^a   Ho, Hong Nerng ^a   Chen, Ding Shinn ^a   Huang, Li Min ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Age distribution; Annual incidence; Kawasaki disease; Season

Indexed keywords

ARTICLE; CHILD; CONTROLLED STUDY; CORONARY ARTERY ANEURYSM; DATA BASE; DISEASE CLASSIFICATION; ENTEROVIRUS 71; EPIDEMIC; FEMALE; GROUPS BY AGE; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; NATIONAL HEALTH INSURANCE; PRIORITY JOURNAL; RECURRENT DISEASE; SEASONAL VARIATION; SEX RATIO; SUMMER; TAIWAN; VIRUS INFECTION; WINTER; ADOLESCENT; AGE DISTRIBUTION; ECONOMICS; HEALTH CARE COST; HOSPITALIZATION; LENGTH OF STAY; PRESCHOOL CHILD; SEASON; STATISTICS;

ADOLESCENT; AGE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; CORONARY ANEURYSM; FEMALE; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; INCIDENCE; INFANT; LENGTH OF STAY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; SEASONS; SEX DISTRIBUTION; TAIWAN;

EID: 16644365210     PISSN: 00314005     EISSN: 00314005     Source Type: Journal    
DOI: 10.1542/peds.2004-0726     Document Type: Article

References (35)

1. Kawasaki T. Pediatric acute febrile mucocutaneous lymph node syndrome with characteristic desquamation of fingers and toes: my clinical observation of fifty cases. Jpn J Allergy. 1967;178:178-222
2. Yanagawa H, Yashiro M, Nakamura Y, et al. Epidemiologic pictures of Kawasaki disease in Japan: from the nationwide incidence survey in 1991 and 1992. Pediatrics. 1995;95:475-479
3. Yanagawa H, Yashiro M, Nakamura Y, et al. Results of the nationwide epidemiologic survey of Kawasaki disease in 1995 and 1996 in Japan. Pediatrics. 1998;102(6). Available at: www.pediatrics.org/cgi/content/full/102/6/e65
4. Yanagawa H, Nakamura Y, Ojima T, et al. Changes in epidemic patterns of Kawasaki disease in Japan. Pediatr Infect Dis J. 1999;18:64-66
5. Yanagawa H, Nakamura Y, Ojima T, et al. Incidence survey of Kawasaki disease in 1997 and 1998 in Japan. Pediatrics. 2001;107(3). Available at: www.pediatrics.org/cgi/content/full/107/3/e33
6. Du ZD, Zhang T, Liang L, et al. Epidemiologic picture of Kawasaki disease in Beijing from 1995 through 1999. Pediatr Infect Dis J. 2002;21:103-107
7. Taubert KA. Epidemiology of Kawasaki disease in the United States and worldwide. Prog Pediatr Cardiol. 1996;28:253-257
8. Newburger JW, Taubert KA, Shulman ST, et al. Summary and abstracts of the seventh international Kawasaki disease symposium. Pediatr Res. 2003;53:153-157
9. Holman RC, Curns AT, Belay ED, Steiner CA, Schonberger LB. Kawasaki syndrome hospitalizations in the United States, 1997 and 2000. Pediatrics. 2003;112:495-501
10. Gardner-Medwin JM, Dolezalova P, Cummins C, Southwood TR. Incidence of Henoch-Schonlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet. 2002;360:1197-1202
11. Royle JA, Williams K, Elliott E, et al. Kawasaki disease in Australia, 1993-95. Arch Dis Child. 1998;78:33-39
12. Schiller B, Fasth A, Bjorkhem G, Elinder G. Kawasaki disease in Sweden: incidence and clinical features. Acta Paediatr. 1995;84:769-774
13. Cheng TM. Taiwan's new national health insurance program: genesis and experience so far. Health Aff. 2003;22:61-76
14. Chang LY, Lin TY, Huang YC. Fulminant neurogenic pulmonary oedema with hand, foot and mouth disease. Lancet. 1998;352:367-368
15. Ho M, Chen ER, Hsu KH, et al. An epidemic of enterovirus 71 infection in Taiwan. N Engl J Med. 1999;341:929-935
16. Park YW, Park IS, Kim CH, et al. Epidemiologic study of Kawasaki disease in Korea, 1997-1999: comparison with previous studies during 1991-1996. J Korean Med Sci. 2002;17:453-456
17. Nakamura Y, Yashiro M, Yanagawa H. Validity of the infectious disease surveillance system on comparison of nationwide surveys of Kawasaki disease during a 10 year period. Nippon Koshu Eisei Zasshi. 2000;47:1029-1035
18. Nakamura Y, Yanagawa I, Kawasaki T. Temporal and geographic clustering of Kawasaki disease in Japan. Prog Clin Biol Res. 1987;250:19-32
19. Keren G, Barzilay Z, Alpert G, Spirer Z, Danon Y. Mucocutaneous lymph node syndrome (Kawasaki disease) in Israel. A review of 13 cases: is pseudomonas infection responsible? Acta Paediatr Scand. 1983;72:455-458
20. Hansen RC. Staphylococcal scalded skin syndrome, toxic shock syndrome, and Kawasaki disease. Pediatr Clin North Am. 1983;30:533-544
21. Reller M, DeCristofaro J, Schwartz DC. Coronary aneurysms in a patient with atypical Kawasaki syndrome and a streptococcal infection. Pediatr Cardiol. 1984;5:205-207
22. Abinun M, Cant AJ. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet. 1994;343:300
23. Anderson DG, Warner G, Barlow E. Kawasaki disease associated with streptococcal infection within a family. J Paediatr Child Health. 1995;31:355-357
24. Barton M, Melbourne R, Morais P, Christie C. Kawasaki syndrome associated with group A streptococcal and Epstein-Barr virus co-infections. Ann Trop Paediatr. 2002;22:257-260
25. Kikuta H, Taguchi Y, Tomizawa K, et al. Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease. Nature. 1988;333:455-457
26. Okano M, Luka J, Thiele GM, Sakiyama Y, et al. Human herpesvirus 6 infection and Kawasaki disease. J Clin Microbiol. 1989;27:2379-2380
27. Marchette NJ, Melish ME, Hicks R, Kihara S, Sam E, Ching D. Epstein-Barr virus and other herpesvirus infections in Kawasaki syndrome. J Infect Dis. 1990;161:680-684
28. Okano M, Thiele GM, Sakiyama Y, Matsumoto S, Purtilo DT. Adenovirus infection in patients with Kawasaki disease. J Med Virol. 1990;32:53-57
29. Kikuta H, Matsumoto S, Osato T. Kawasaki disease and Epstein-Barr virus. Acta Paediatr Jpn. 1991;33:765-77
30. Lin CY, Chen IC, Cheng TI, Liu WT, Hwang B, Chiang BN. Virus-like particles with reverse transcriptase activity associated with Kawasaki disease. Med Virol. 1992;38:175-182
31. Chua PK, Nerurkar VR, Yu Q, et al. Lack of association between Kawasaki syndrome and infection with parvovirus B19, human herpesvirus 8, TT virus, GB virus C/hepatitis G virus or Chlamydia pneumoniae. Pediatr Infect Dis J. 2000;19:477-479
32. Schrag SJ, Besser RE, Olson C, et al. Lack of association between Kawasaki syndrome and Chlamydia pneumoniae infection: an investigation of a Kawasaki syndrome cluster in San Diego County. Pediatr Infect Dis J. 2000;19:17-22
33. Kafetzis DA, Maltezou HC, Constantopoulou I, et al. Lack of association between Kawasaki syndrome and infection with Rickettsia conorii, Rickettsia typhi, Coxiella burnetii or Ehrlichia phagocytophila group. Pediatr Infect Dis J. 2001;20:703-706
34. Akiyama T, Osawa N, Shimanuki K, Yashiro K, Oyake T. Possible role of Streptococcus pyogenes in mucocutaneous lymph node syndrome. XII. Variable responses of platelets in MCLS seem to be explainable by streptococcal pyrogenic exotoxin. Acta Paediatr Jpn. 1991;33:20-26
35. Morita A, Imada Y, Igarashi H, Yutsudo T. Serologic evidence that streptococcal superantigens are not involved in the pathogenesis of Kawasaki disease. Microbiol Immunol. 1997;41:895-900